Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cassiopea S.p.A.
  6. News
  7. Summary
    SKIN   IT0005108359

CASSIOPEA S.P.A.

(SKIN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cassiopea S p A : Enters License, Supply Deals for Acne Treatment in North America

07/26/2021 | 02:58am EDT


© MT Newswires 2021
All news about CASSIOPEA S.P.A.
09/13CASSIOPEA S P A : Public Investor Presentation H.C. Wainwright Annual Global Con..
PU
09/10CASSIOPEA S P A : Female Androgenetic Alopecia Treatment Shows Improvement in Mi..
MT
09/10Cassiopea SpA Announces Topline Results of Phase II Proof of Concept Trial of..
DJ
09/10Cassiopea SpA Announces Topline Results of Phase II Proof of Concept Trial of..
CI
08/31CASSIOPEA S P A : Concludes License, Supply Deal for Acne Drug Winlevi
MT
08/31EQS-ADHOC : Cassiopea SpA and Sun Pharma announce the expiry of the HSR Act proc..
DJ
07/29CASSIOPEA S P A : H1 Loss Swells to $7 Million
MT
07/29CASSIOPEA S P A : Announces Results for First Half of 2021
PU
07/29CASSIOPEA S P A : Half Year 2021 Financial Results Presentation
PU
07/29CASSIOPEA S P A : Half Year Report 2021
PU
More news
Financials
Sales 2021 38,7 M 45,4 M 45,4 M
Net income 2021 24,3 M 28,5 M 28,5 M
Net cash 2021 27,9 M 32,7 M 32,7 M
P/E ratio 2021 14,3x
Yield 2021 -
Capitalization 353 M 415 M 414 M
EV / Sales 2021 8,39x
EV / Sales 2022 19,2x
Nbr of Employees 11
Free-Float 41,2%
Chart CASSIOPEA S.P.A.
Duration : Period :
Cassiopea S.p.A. Technical Analysis Chart | SKIN | IT0005108359 | MarketScreener
Technical analysis trends CASSIOPEA S.P.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 32,82 €
Average target price 52,30 €
Spread / Average Target 59,3%
EPS Revisions
Managers and Directors
Diana Harbort Chief Executive Officer & Executive Director
Pierpaolo Guzzo Chairman & Chief Financial Officer
Luigi Moro Chief Scientific Officer
Alessandro Mazzetti Chief Medical Officer
Martina Cartwright Senior Director-Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
CASSIOPEA S.P.A.-25.98%415
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850